Pharmacists in Hampton, AR Accepting Medicare
1 Pharmacists found. Showing 1 - 1
 Dr. Kristina Ables, PHARMACIST Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 344 South Lee St, Hwy 167s, Hampton, AR 71744 Phone: 870-798-4247 Fax: 870-798-4934 |
News Archive
When it comes health matters Australia appears to be a war zone
If it is not the medical profession fighting with the government and states, it is doctors fighting doctors which is currently what has happened over the 2020 summit.
Sodium oxybate to garner over 15% of the fibromyalgia drug market despite safety concerns
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, despite potential safety concerns, Jazz Pharmaceuticals/UCB's sodium oxybate (JZP-6) will account for more than 15 percent of the fibromyalgia drug market in 2018 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan. Sodium oxybate has demonstrated robust efficacy in Phase III clinical trials for fibromyalgia and interviewed thought leaders are impressed with its effect on several key symptom domains of fibromyalgia, which include pain, sleep and fatigue.
Heat shock proteins may play role in triggering Schistosoma invasion
A protein known for helping cells withstand stress may also act as a switch that triggers free-swimming Schistosoma larvae to begin penetrating the skin and transforming into the parasitic flatworms that burden more than 240 million people worldwide with schistosomiasis.
Preconception care can significantly lower adverse birth outcomes in diabetic women
Pregnant women with diabetes are at an increased risk for many adverse birth outcomes. Preconception care (PCC) can significantly lower these risks by helping pregnant mothers with diabetes control their glucose levels, resulting in healthier babies and less money spent on complicated deliveries and lifelong medical complications.
USHIFU announces results from clinical investigation of Sonablate HIFU to treat prostate cancer
USHIFU LLC, a world leader in minimally invasive high intensity focused ultrasound technologies and manufacturer of the Sonablate 500 (Sonablate) medical device, announces results from the first-ever prospective clinical investigation of HIFU with the Sonablate to focally treat prostate cancer, a modality in which only the confirmed cancerous regions within the gland are treated as opposed to the entire prostate. Results from the study appear in this month's Journal of Urology.
› Verified 3 days ago